Medication-Related Interferences in Laboratory Testing: A Practical Guide for Nursing Technicians, Clinical Pharmacists, and Laboratory Specialists

Laboratory diagnostics are indispensable to modern healthcare, yet the integrity of test results can be compromised by medication-related interference (MRI), a significant and underappreciated threat to patient safety. Erroneous laboratory data stemming from MRI can precipitate a cascade of clinical errors, including misdiagnosis, delayed or inappropriate treatment, and unnecessary additional testing. This review offers a practical, evidence-based guide for the key professionals’ integral to the laboratory testing process: nursing technicians, clinical pharmacists, and laboratory specialists. We systematically explore the foundational mechanisms of interference, classifying them into physiological (in vivo) effects, where a drug's pharmacodynamic or toxic action genuinely alters analyte levels, and analytical (in vitro) effects, where a drug or its metabolite directly disrupts the assay methodology. The review examines the vulnerabilities of common analytical platforms—spectrophotometry, immunoassays, enzymatic methods, and chromatography—to such interferences. A substantial compendium details clinically significant MRIs caused by major drug classes, with a particular focus on the profound and dangerous impact of high-dose biotin supplementation on immunoassays. The central aim of this guide is to delineate the distinct yet synergistic roles of the multidisciplinary team. It highlights the nursing technician's pivotal role in the pre-analytical phase, the clinical pharmacist's expertise in proactive drug identification and management, and the laboratory specialist's critical function in result validation and interference investigation. By elucidating the complexities of MRI and championing a framework for robust interprofessional collaboration, this guide seeks to arm healthcare teams with the knowledge and strategies required to protect the integrity of laboratory data, thereby enhancing clinical decision-making and safeguarding patient safety.

Authors

Publication Details

Journal
Saudi Journal of Medical and Pharmaceutical Sciences
Published
2025-07-19
DOI
https://doi.org/10.36348/sjmps.2025.v11i07.018
Primary Topic
Pharmaceutical studies and practices
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Medication-Related Interferences in Laboratory Testing: A Practical Guide for Nursing Technicians, Clinical Pharmacists, and Laboratory Specialists

Sahar Zabin Alotaibi, Fahad E. Alotaibi, Nawal Mohammad Theab, Reem Bandar Alhajri et al.
Saudi Journal of Medical and Pharmaceutical Sciences
Pharmaceutical studies and practices
article

Medication-Related Interferences in Laboratory Testing: A Practical Guide for Nursing Technicians, Clinical Pharmacists, and Laboratory Specialists

Sahar Zabin Alotaibi, Fahad E. Alotaibi, Nawal Mohammad Theab, Reem Bandar Alhajri, Mashael Fawaz Almishrafi, Suliman Saleh Alomayri, Ali Barjas Alsahli, Albandari Khammas Alenazi, Sarah Saad Alosail
article en

Abstract

Laboratory diagnostics are indispensable to modern healthcare, yet the integrity of test results can be compromised by medication-related interference (MRI), a significant and underappreciated threat to patient safety. Erroneous laboratory data stemming from MRI can precipitate a cascade of clinical errors, including misdiagnosis, delayed or inappropriate treatment, and unnecessary additional testing. This review offers a practical, evidence-based guide for the key professionals’ integral to the laboratory testing process: nursing technicians, clinical pharmacists, and laboratory specialists. We systematically explore the foundational mechanisms of interference, classifying them into physiological (in vivo) effects, where a drug's pharmacodynamic or toxic action genuinely alters analyte levels, and analytical (in vitro) effects, where a drug or its metabolite directly disrupts the assay methodology. The review examines the vulnerabilities of common analytical platforms—spectrophotometry, immunoassays, enzymatic methods, and chromatography—to such interferences. A substantial compendium details clinically significant MRIs caused by major drug classes, with a particular focus on the profound and dangerous impact of high-dose biotin supplementation on immunoassays. The central aim of this guide is to delineate the distinct yet synergistic roles of the multidisciplinary team. It highlights the nursing technician's pivotal role in the pre-analytical phase, the clinical pharmacist's expertise in proactive drug identification and management, and the laboratory specialist's critical function in result validation and interference investigation. By elucidating the complexities of MRI and championing a framework for robust interprofessional collaboration, this guide seeks to arm healthcare teams with the knowledge and strategies required to protect the integrity of laboratory data, thereby enhancing clinical decision-making and safeguarding patient safety.

Saudi Journal of Medical and Pharmaceutical SciencesVol. 11(07)
Openalex Percentile: Top 75%
Pharmaceutical studies and practices
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.